Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplastic Anemia

Safety Study of AMG 531 in Japanese Subjects With ITP

NCT00305435 ·Status: COMPLETED ·Phase: PHASE2

Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)

NCT00472290 ·Status: COMPLETED ·Phase: NA

Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects

NCT02404025 ·Status: COMPLETED ·Phase: PHASE2

Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia

NCT06613880 ·Status: RECRUITING ·Phase: PHASE2

Avatrombopag Combined With IST as First-line Treatment for SAA

NCT05720234 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia

NCT05018936 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

UI-Romi-02; Romiplostim Added to Standard of Care for Treatment Naive and Relapsed or Refractory Severe Aplastic Anemia

NCT07001254 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia

NCT02148133 ·Status: COMPLETED ·Phase: PHASE2

An Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Hetrombopag in Patients With ITP or AA

NCT05333861 ·Status: NOT_YET_RECRUITING

Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia

NCT05325593 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT

NCT06693791 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Severe Aplastic Anemia （SAA） Patient

NCT03557099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Open Label Extension Study of AMG 531 in Japanese Subjects With ITP

NCT00440037 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Using ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem Cell

NCT01980030 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP

NCT02338414 ·Status: UNKNOWN ·Phase: PHASE2

Hetrombopag or Placebo in Treatment-Naive Severe Aplastic Anemia

NCT03825744 ·Status: COMPLETED ·Phase: PHASE3

Real-world Outcomes of Aplastic Anemia Patients Treated With Eltrombopag: A Medical Claims Database Study

NCT06991894 ·Status: COMPLETED

Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia

NCT07206823 ·Status: RECRUITING ·Phase: NA

Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

NCT04328727 ·Status: COMPLETED ·Phase: PHASE2

A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects

NCT05088642 ·Status: COMPLETED ·Phase: PHASE1

Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)

NCT00907478 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults

NCT01013181 ·Status: COMPLETED

Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia Patients

NCT04403321 ·Status: COMPLETED ·Phase: PHASE2

Evaluating the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)

NCT00111475 ·Status: COMPLETED ·Phase: PHASE2

Extension Study of Hetrombopag in Severe Aplastic Anemia

NCT04961710 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3